{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 448131419
| IUPAC_name = (''RS'')-7-(3-<nowiki/>{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1''H''-purine-2,6-dione
| image = Reproterol.svg
| width = 260

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|reproterol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_DE = Rx only
| legal_status =
| routes_of_administration = Inhalation ([[Metered-dose inhaler|MDI]]), [[Intravenous therapy|IV]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 54063-54-6
| ATC_prefix = R03
| ATC_suffix = AC15
| ATC_supplemental =  
| PubChem = 25654
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1095607
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 11941YC6RN
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08474
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 23898


<!--Chemical data-->
| chemical_formula =  
| C=18 | H=23 | N=5 | O=5 
| molecular_weight = 389.406 g/mol
| smiles = CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C18H23N5O5/c1-21-16-15(17(27)22(2)18(21)28)23(10-20-16)5-3-4-19-9-14(26)11-6-12(24)8-13(25)7-11/h6-8,10,14,19,24-26H,3-5,9H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = WVLAAKXASPCBGT-UHFFFAOYSA-N
}}

'''Reproterol''' ([[International Nonproprietary Name|INN]]) is a short-acting<ref>{{cite journal|last1=Küpper|first1=T|last2=Goebbels|first2=K|last3=Kennes|first3=LN|last4=Netzer|first4=NC|title=Cromoglycate, reproterol, or both—what's best for exercise-induced asthma?|journal=Sleep & breathing = Schlaf & Atmung|date=December 2012|volume=16|issue=4|pages=1229–35|pmid=22198635|doi=10.1007/s11325-011-0638-2}}</ref> [[Beta2-adrenergic agonist|β<sub>2</sub> adrenoreceptor agonist]] used in the treatment of [[asthma]].<ref>Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both?
Respiration. 1999;66(3):210-1. {{PMID|10364735}}</ref>

==References==
<references/>

{{Drugs for obstructive airway diseases}}
{{Adrenergic agonists}}

[[Category:Antiasthmatic drugs]]
[[Category:Beta-adrenergic agonists]]
[[Category:Xanthines]]
[[Category:Phenethylamines]]
[[Category:Resorcinols]]

{{respiratory-system-drug-stub}}